Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia

Permanent link
https://hdl.handle.net/10037/26869
DOI
https://doi.org/10.3201/eid2802.211640
Thumbnail
View/Open
Published version (PDF)
Date
2022-02
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
Krieger, Ekaterina Anatoljevna; Kudryavtsev, Alexander V; Sharashova, Ekaterina; Postoev, Vitaly; Belova, Natalia; Shagrov, Leonid; Zvedina, Julia; Drapkina, Oxana; Kontsevaya, Anna; Shalnova, Svetlana; Brenn, Tormod; Shkolnikov, Vladimir M.; Eggo, Rosalind M.; Leon, David Adrew
Abstract
Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40–75 years of age, 65% were seropositive for IgG. Fifteen percent of participants had been vaccinated; of those, 97% were seropositive.
Publisher
Centers for Disease Control and Prevention
Citation
Krieger, Kudryavtsev, Sharashova, Postoev, Belova, Shagrov, Zvedina, Drapkina, Kontsevaya, Shalnova, Brenn, Shkolnikov, Eggo, Leon DA. Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia. Emerging Infectious Diseases. 2022;28(2):463-465
Metadata
Show full item record
Collections
Copyright 2022 The Author(s)